Our team contributes to peer-reviewed research across genetics, microbiology, and clinical chemistry — because good diagnostics starts with good science.
Highlighted from our most recent and impactful contributions to the field.
Featured
Nature Genetics · 2024
Comprehensive analysis of next-generation sequencing technologies and their transformative impact on precision medicine. This study explores novel methodologies for rapid genetic diagnosis and personalised treatment strategies — examining how diagnostic labs can move from reactive testing to proactive health intelligence.
Peer-reviewed work contributing to the advancement of diagnostic medicine and laboratory science.
Nature · 2024
Revolutionary CRISPR-based detection methods for rapid identification of infectious diseases, demonstrating high sensitivity and specificity in clinical settings with point-of-care applications that reduce time-to-result from days to hours.
The Lancet · 2024
Comprehensive global analysis of antimicrobial resistance patterns across 204 countries, revealing critical insights into pathogen resistance mechanisms and their impact on mortality rates, informing clinical sensitivity testing protocols.
JAMA · 2024
Systematic review of artificial intelligence and machine learning applications in laboratory diagnostics, analysing accuracy improvements, workflow integration challenges, and the practical considerations for clinical implementation at scale.
Cell · 2024
Discovery of novel immunological biomarkers for early detection of autoimmune disorders, demonstrating improved diagnostic accuracy and potential for personalised treatment approaches — with implications for how labs design their immunology panels.
Clinical Chemistry · 2024
Best practices and quality control protocols for automated high-throughput laboratory systems, addressing error detection, standardisation, and regulatory compliance challenges across different instrument platforms.
NEJM · 2023
Real-world evidence of pharmacogenomic testing implementation showing improved medication efficacy, reduced adverse events, and cost-effectiveness in diverse patient populations — a practical model for labs looking to expand into precision medicine.
Measuring how our work moves the field — not just within our walls, but across the wider diagnostic community.
Published across leading journals in genetics, microbiology, and clinical chemistry.
Referenced by researchers and clinicians across more than 30 countries.
Active partnerships with academic medical centres and research institutions.
Including best paper citations from IFCC and national laboratory science bodies.